[A05-19B] Ginkgo compounds in Alzheimer's disease

Last updated 21.11.2008

Project no.:
A05-19B

Commission:
Commission awarded on 22.02.2005 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Drug Assessment

Application field:
Head and nerves

10.09.2009

Alzheimer’s disease: only a few therapies provide proof of benefit to patients

Cholinesterase inhibitors and ginkgo may alleviate some symptoms – Non-drug approaches are insufficiently investigated – Marked increase in supporting...

21.11.2008

Ginkgo biloba in Alzheimer's disease: evidence from studies is mixed

With high-dose Ginkgo, patients cope better with daily activities / Studies from Eastern Europe showing particularly positive effects dominate the assessment

Accompanying information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealth.org.

Contact

Info Service

Subscribe to daily updated information on projects, calls for tender, and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.